Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eslicarbazepine Acetate in Fibromyalgia
NCT01820585Phase 2Completed
- Sponsor
- BIAL
- Start
- Apr 2009
- Primary completion
- Sep 2010
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of eslicarbazepine acetate in fibromyalgia (FM), sponsored by BIAL. Started Apr 2009; status: completed.
02
Drugs
eslicarbazepine acetate
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT01820585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01820585.